Systemic diclofenac sodium to maintain mydriasis during phacoemulsification. (Record no. 9577057)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01322 a2200337 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250513143623.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 199807s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0886-3350 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/s0886-3350(98)80266-6 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Sidiki, S S |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19980709 |
245 00 - TITLE STATEMENT | |
Title | Systemic diclofenac sodium to maintain mydriasis during phacoemulsification. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of cataract and refractive surgery |
Date of publication, distribution, etc. | May 1998 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 684-8 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Administration, Oral |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Inflammatory Agents, Non-Steroidal |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclooxygenase Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diclofenac |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mydriatics |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ophthalmic Solutions |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phacoemulsification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pupil |
General subdivision | drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wykes, W N |
773 0# - HOST ITEM ENTRY | |
Title | Journal of cataract and refractive surgery |
Related parts | vol. 24 |
-- | no. 5 |
-- | p. 684-8 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/s0886-3350(98)80266-6">https://doi.org/10.1016/s0886-3350(98)80266-6</a> |
Public note | Available from publisher's website |
No items available.